United States Drug Enforcement Administration Executive and Leadership Team

Frank Kalder, the Chief Financial Officer at United States Drug Enforcement Administration, directs the agency's financial strategy and fiscal management. This executive is responsible for overseeing all aspects of financial planning, budgeting, and resource allocation to support the enforcement of controlled substances laws. Kalder ensures financial integrity and compliance across all agency operations, managing funds critical for investigations, interdiction efforts, and support programs aimed at reducing illicit drug availability. The Chief Financial Officer's role is essential for sustaining the agency's operational capacity and its ability to bring organizations involved in drug trafficking to justice. Frank Kalder's financial leadership enables the United States Drug Enforcement Administration to effectively deploy resources in complex domestic and international environments, safeguarding fiscal responsibility while advancing the agency's core mission.

Esther Chege, the Chief Operating Officer at United States Drug Enforcement Administration, directs the agency's operational framework, ensuring efficient execution of its mandate to enforce controlled substances laws. Overseeing daily activities, Chege coordinates departmental functions to support the broader mission of combating illicit drug trafficking. This leadership position involves optimizing resource allocation and streamlining processes to enhance the agency's effectiveness in bringing organizations involved in drug manufacturing and distribution to justice. Chege's operational oversight extends to managing inter-agency collaborations and ensuring seamless integration of enforcement strategies across various divisions. The Chief Operating Officer's role is critical in maintaining the agency's capacity to address complex challenges in the domestic and international drug trade. Esther Chege drives the implementation of strategic initiatives that bolster the agency's operational readiness and responsiveness to evolving threats within the controlled substances landscape.

Gary Owen, the Associate Administrator and Chief Operating Officer for Business Operations at United States Drug Enforcement Administration, leads the critical business functions that underpin the agency's enforcement activities. This executive directs the operational framework for all business-related aspects, ensuring efficient resource management and administrative support for the core mission of enforcing controlled substances laws. Owen's oversight encompasses financial operations, human resources, and technological infrastructure, all vital for supporting investigations and interdiction efforts against drug trafficking organizations. The Associate Administrator and Chief Operating Officer for Business Operations plays a pivotal role in optimizing the agency's internal processes to enhance its effectiveness in combating illicit drug availability domestically and internationally. Gary Owen drives strategic business operations that empower the United States Drug Enforcement Administration to execute its mandate with precision and efficiency.

Marc Kuzmicki, the Chief of Staff at United States Drug Enforcement Administration, provides strategic counsel and manages the administrative operations supporting the agency's leadership. This role involves coordinating high-level initiatives, facilitating communication between different branches, and ensuring the effective implementation of agency-wide policies. Kuzmicki's responsibilities include overseeing special projects and advising on critical decisions related to enforcing controlled substances laws. The Chief of Staff's position is vital for maintaining organizational coherence and driving forward the agency's objectives in combating illicit drug organizations. Marc Kuzmicki ensures that the agency's strategic priorities are translated into actionable plans, supporting the mission to reduce the availability of controlled substances on domestic and international markets. This executive function is key to the agency's ability to navigate complex legal and operational landscapes.

Katie Kruger, the Acting Chief of Staff at United States Drug Enforcement Administration, supports the agency's executive leadership by managing critical administrative functions and strategic projects. This role involves coordinating interdepartmental efforts to enforce controlled substances laws and regulations effectively. Kruger facilitates communication channels, ensuring alignment across various operational units focused on dismantling drug trafficking organizations. The Acting Chief of Staff's position is crucial for maintaining operational momentum and supporting the agency's mission to reduce the availability of illicit substances. Katie Kruger contributes to the strategic planning and execution of initiatives designed to address the complex challenges posed by the global drug trade, ensuring the agency's continued effectiveness in its enforcement activities.